The Optimal Injection Site for a 3D Guided Inferior Alveolar Nerve Block Device (IANBD)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBoston University

About this trial

Given the thicker cortical bone in the mandible compared to the maxilla, mandibular teeth cannot be effectively anesthetized via local infiltration anesthesia. Instead, clinicians typically perform regional anesthesia and most commonly, Inferior Alveolar Nerve block (IANB). However, the inferior alveolar nerve is deeply submerged by surrounding structures of bone, muscles, ligaments and vessels. Traditional IANB is a technique by using anatomical landmarks not directly related to Inferior Alveolar Nerve (IAN) to approximate the location of mandibular foramen, where IAN enters mandible. IANB is considered a blind technique and known for the lack of accuracy and precision. The failure rate can be as high as 30-45%. In contrast, the investigator's cone beam computed tomography (CBCT) guided IANB device (IANBD) effectively directs the needle to the mandibular foramen which improves the success rate of the IANB on the first attempt, minimizes injection tissue damage, and reduces patient discomfort.

In this proof of concept trial, a 3D printed CBCT guided IANBD will be used to administer anesthesia at three injection sites instead of the traditional IANB technique. Participants will be consented patients at the postdoctoral endodontic treatment center, Department of Endodontics, Boston University (BU) Henry M. Goldman School of Dentistry.

The goal of this research is to to evaluate the acceptability, safety, and effectiveness of guided anesthesia using the IANBD by enrolling 10 subjects who require non-surgical endodontic therapy with a simple, affordable and reliable prototype to be used by clinicians in the dental care setting.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient of Henry M. Goldman School of Dentistry (GSDM)

Medical History indicating American Society of Anesthesiology (ASA)1

Need Non-surgical Endodontic Therapy on Mandibular Molar or Premolar

Asymptomatic pulpal diagnosis (normal, necrotic, asymptomatic irreversible pulpitis, retreatment with no symptoms)

Disqualifiers

Allergy to lidocaine or articaine

Resin allergy

Normal teeth unresponsive to thermal testing (ie calcified chamber)

Prior jaw surgery

Trial design

Design model

Single group

Treatments tested in this trial

  • IANBD 3D guided approach

    Procedure/Surgery

    The IANBD will be used to administer the dental anesthetic 2mm medial to the lingula

Treatment groups

10 Participants
are divided into 1 treatment group
Group A: IANBD guided Inferior Alveolar Nerve block (IANB) injectionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Participant acceptability

For this proof of concept trial, the investigators developed a questionnaire with 3 open-ended questions asking participants; 1) did they have mandibular anesthesia before for a dental procedure and if yes how did this compare, 2) was the size of the device acceptable, and 3) was the taste of the device acceptable. The responses will be assessed to determine if overall the IANBD was acceptable or not to each participant.

Time frame
30 minutes post dental procedure
2

Clinician acceptability

For this proof of concept trial, the investigators developed a questionnaire with 5 open-ended questions asking clinicians; 1) how easy was it to set up the IANBD, 2) how time consuming was it to use the IANBD, 3) could you visualize the needle with the device, 4) are you likely to switch to the IANBD, and 5) compare this technique with previous IANB methods. The responses will be assessed to determine if overall the IANBD was acceptable or not to each clinician.

Time frame
30 minutes post dental procedure
3

Safety of IANBD based on number of adverse events

The number of adverse events that occur will be abstracted from records of the procedure for each participant.

Time frame
at the end of the study, about 2 years
4

Safety of IANBD based on type of adverse events

The types of adverse events that occur will be abstracted from records of the procedure for each participant.

Time frame
at the end of the study, about 2 years

Secondary outcomes

1

Pulp vitality

The Cold test will be done to assess pulpal vitality/anesthesia. If the Cold test is negative, the anesthesia is successful.

Time frame
baseline, 1 minute, 4 minutes, 7 minutes, 10 minutes, 13 minutes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.